EligibleTrials

Clinical trials recruiting for Ductal Breast Carcinoma In Situ

4
Recruiting trials
17
US states with sites
2
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 2 1Not applicable 3

Drugs and treatments being studied

InterventionTrials
Hypofractionated Radiation Therapy1

Where trials are recruiting (top US states)

StateRecruiting trials
Texas2
Arizona1
California1
Colorado1
Florida1
Georgia1
Illinois1
Maryland1
Massachusetts1
Michigan1
Missouri1
New York1

Top cities

Houston, Texas 2Akron, Ohio 1Atlanta, Georgia 1Aurora, Colorado 1Baltimore, Maryland 1Boston, Massachusetts 1Brooklyn, New York 1Cleveland, Ohio 1Columbus, Ohio 1Dallas, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Ductal Breast Carcinoma In Situ often also study these conditions. Each links to its own recruiting-trial list.

Breast cancer 2239Prognostic Stage IIIC Breast Cancer AJCC v8 6Prognostic Stage IIIB Breast Cancer AJCC v8 5Prognostic Stage IIIA Breast Cancer AJCC v8 5Prognostic Stage III Breast Cancer AJCC v8 5Prognostic Stage IIB Breast Cancer AJCC v8 3Prognostic Stage IIA Breast Cancer AJCC v8 3Prognostic Stage II Breast Cancer AJCC v8 3Prognostic Stage IB Breast Cancer AJCC v8 3Prognostic Stage IA Breast Cancer AJCC v8 3

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Ductal Breast Carcinoma In Situ trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.